Trial
NCT00958776
A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
BioCryst Pharmaceuticals
Collaborators
Department of Health and Human Services
Condition
Cough
Intervention
Peramivir+SOC
Why stopped
This study was terminated for futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-02-12